___

🇺🇸#REGN #отчетность Regeneron Pharmaceuticals Q3 Non-GAAP -EPS of $8.36 beats by $1.37; GAAP EPS of $7.39 beats by $1.04. -Revenue of $2.29B (+31.6% Y/Y) beats by $200M.